Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024

Global Non-Small Cell Lung Cancer (NSCLC) Market Report 2024

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

Name: Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Non-Small Cell Lung Cancer (NSCLC) Market Definition

Non-small cell lung cancer (NSCLC) is a type of epithelial lung cancer that develops in the tissues of the lungs and is characterized by the abnormal growth of cells. It is primarily caused by long-term smoking, genetic mutations, air pollution, and secondhand smoke.

The main types of non-small cell lung cancer (NSCLC) are squamous cell carcinoma, large cell carcinoma, adenocarcinoma, and others. Squamous cell carcinoma is a type of cancer that arises from the squamous epithelial cells and can occur in other areas of the body. The various types of therapies are included, such as radiotherapy, laser therapy, photodynamic therapy (PDT), and others, with various distribution channels involved, including hospital pharmacies, online pharmacies, and others.

Non-Small Cell Lung Cancer (NSCLC) Market Segmentation

The non-small cell lung cancer (nsclc) market covered in this report is segmented –

1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types

2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels

Global Non Small Cell Lung Cancer NSCLC Market Size 2023 to 2028: Graph

Non-Small Cell Lung Cancer (NSCLC) Market Size 2024 And Growth Rate

The non-small cell lung cancer (nsclc) market size has grown rapidly in recent years. It will grow from $18.02 billion in 2023 to $20.1 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to evolution of immunotherapy, genomic profiling and precision medicine, expansion of clinical trials, smoking cessation initiatives.

Non-Small Cell Lung Cancer (NSCLC) Market Growth Forecast

The non-small cell lung cancer (nsclc) market size is expected to see rapid growth in the next few years. It will grow to $29.95 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to emerging combination therapies, integration of artificial intelligence (ai), expansion of personalized vaccines, global collaborations in research, patient-centric care. Major trends in the forecast period include integration of telemedicine in oncology, liquid biopsy technologies, advances in diagnostic technologies, adoption of minimally invasive surgical techniques, immune checkpoint inhibitors.

Book your 30 minutes free consultation with our research experts

Non-Small Cell Lung Cancer (NSCLC) Market Driver: Rising Tobacco Consumption Fuels Growth In The Non-Small Cell Lung Cancer (NSCLC) Market

The increasing rate of tobacco consumption is expected to propel the growth of the non-small cell lung cancer (NSCLC) market going forward. Tobacco consumption refers to the use of tobacco products by individuals, typically in the form of smoking, chewing, or snuffing, which introduces nicotine and other chemicals into the body. Tobacco smoke contains several carcinogens that can damage the DNA (deoxyribonucleic acid) in lung cells, leading to mutations and the uncontrolled growth of cancerous cells, including non-small-cell lung cancer (NSCLC). For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. The total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the increasing rate of tobacco consumption is driving the growth of the non-small cell lung cancer (NSCLC) market.

Non-Small Cell Lung Cancer (NSCLC) Market Driver: Rising Air Pollution Levels Linked To Increased Non-Small Cell Lung Cancer (Nsclc) Cases

Increasing air pollution is expected to propel the growth of the non-small cell lung cancer (NSCLC) market going forward. Air pollution refers to harmful substances, often in the form of gases or particles, in the Earth's atmosphere that can adversely affect human health. Air pollution can increase the risk of non-small cell lung cancer by causing inflammation, DNA damage, and mutations in lung cells, leading to cancerous tumors. For instance, in June 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, air and household air pollution was associated with 7 million premature deaths annually. Additionally, around 2.4 billion people are exposed to dangerous levels of household air pollution while using polluting open fires for cooking fueled by kerosene, biomass, and coal. Furthermore, in September 2022, according to the World Bank, a US-based financial institution, the health damage caused by air pollution will amount to $8.1 trillion a year, equivalent to 6.1% of global GDP. Therefore, increasing air pollution is expected to propel the growth of the non-small cell lung cancer (NSCLC) market.

Global Non-Small Cell Lung Cancer (NSCLC) Market Major Players

Major companies operating in the non-small cell lung cancer (nsclc) market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Clovis Oncology, Revolution Medicines

Global Non-Small Cell Lung Cancer (NSCLC) Market Restraint: Impact Of Medication Side Effects On Immunotherapy For Non-Small Cell Lung Cancer

The medication side effects of several treatments, such as immunotherapy used for the treatment of non-small cell lung cancer, may restrain the market's growth during the forecast period. Immunotherapy is a medical treatment that harnesses and enhances the body's immune system to fight diseases, particularly cancer. Immunotherapy has significantly improved survival and quality of life for non-small cell lung cancer patients, with fewer side effects than traditional chemotherapy drugs. For instance, in April 2021, according to the National Cancer Institute, a US-based government agency, over 40% of patients experienced immune-related side effects that remained for at least three months after stopping their immune checkpoint inhibitor treatment. Therefore, the medication side effects of several treatments, such as immunotherapy, are hindering the growth of the non-small cell lung cancer market.

Global Non-Small Cell Lung Cancer (NSCLC) Market Trend: Rising Focus Of Companies To Embrace Advance Treatments To Gain Competitive Advantage

Major Companies operating in the non-small cell lung cancer (NSCLC) market are focused on developing multiple treatment options, such as monotherapy treatments, to gain a competitive edge. Monotherapy treatment is the use of a single drug or therapy to treat a medical disorder or condition, and it involves utilizing a single method or treatment approach rather than a combination of multiple interventions. For instance, in June 2022, Novartis AG, a Switzerland-based pharmaceutical company, received approval from the European Commission (EC), a Belgium-based governing body, for Tabrecta (capmatinib) for the treatment of adult patients with advanced non-small cell lung cancer with METex14 skipping. It offers a novel targeted therapeutic option for patients in Europe who have received prior treatment and have advanced non-small cell lung cancer (NSCLC) that has mutations that cause MET exon 14 (METex14) skipping. It is the most popular targeted treatment for advanced NSCLC and has modifications that cause METex14 skipping.

Non-Small Cell Lung Cancer (NSCLC) Market Merger And Acquisition: Bristol-Myers Squibb Strengthens Nsclc Treatment Portfolio With Acquisition Of Turning Point Therapeutics

In August 2022, Bristol-Myers Squibb, a US-based pharmaceutical company, acquired Turning Point Therapeutics for $4.1 billion. This acquisition is expected to improve Bristol-Myers Squibb's capability to treat ROS1-positive non-small cell lung cancer patients with Turning Point's primary treatment, repotrectinib. Repotrectinib is a promising new therapy that can potentially improve outcomes for patients with ROS1-positive non-small-cell lung cancer. Turning Point Therapeutics is a US-based pharmaceutical company specializing in developing precision medicines for non-small-cell lung cancer.

Regional Outlook For The Global Non-Small Cell Lung Cancer (NSCLC) Market

North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (nsclc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-small cell lung cancer (nsclc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The non-small cell lung cancer (NSCLC) market includes revenues earned by entities by providing services such as targeted therapies, radiation therapies, imaging tests, biopsy, bronchoscopy, and lung function tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-small cell lung cancer (NSCLC) market also includes sales of chemotherapy drugs such as cisplatin, carboplatin, and pemetrexed epidermal growth factor receptor (EGFR) inhibitors such as erlotinib, afatinib, and gefitinib, as well as pain medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The non-small cell lung cancer (NSCLC) market research report is one of a series of new reports from The Business Research Company that provides non-small cell lung cancer (NSCLC) market statistics, including non-small cell lung cancer (NSCLC) industry global market size, regional shares, competitors with a non-small cell lung cancer (NSCLC) market share, detailed non-small cell lung cancer (NSCLC) market segments, market trends and opportunities, and any further data you may need to thrive in the non-small cell lung cancer (NSCLC) industry. This non-small cell lung cancer (NSCLC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Non-Small Cell Lung Cancer (NSCLC) Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$20.1 billion
Revenue Forecast In 2033	$29.95 billion
Growth Rate	CAGR of 10.5% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types 2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies 3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution Channels
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; GlaxoSmithKline Plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Viatris Inc; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; UCB S.A.; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Limited; Cipla Limited; Ferring B.V.; Hikma Pharmaceuticals plc; Amneal Pharmaceuticals LLC; Zydus Lifesciences Ltd.; Lupin Limited; Torrent Pharmaceuticals Ltd.; Almirall S.A.; Clovis Oncology; Revolution Medicines
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Non-Small Cell Lung Cancer (NSCLC) Market Characteristics

3. Non-Small Cell Lung Cancer (NSCLC) Market Trends And Strategies

4. Non-Small Cell Lung Cancer (NSCLC) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Non-Small Cell Lung Cancer (NSCLC) Market Size and Growth

5.1. Global Non-Small Cell Lung Cancer (NSCLC) Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Non-Small Cell Lung Cancer (NSCLC) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Non-Small Cell Lung Cancer (NSCLC) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Small Cell Lung Cancer (NSCLC) Market Segmentation

6.1. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Squamous Cell Carcinoma

Large Cell Carcinoma

Adenocarcinoma

Other Types

6.2. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Radiotherapy

Laserthearpy

Photodynamic Therapy (PDT)

Other Therapies

6.3. Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacy

Online Pharmacy

Other Distribution Channels

7. Non-Small Cell Lung Cancer (NSCLC) Market Regional And Country Analysis

7.1. Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market

8.1. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Small Cell Lung Cancer (NSCLC) Market

9.1. China Non-Small Cell Lung Cancer (NSCLC) Market Overview

9.2. China Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Small Cell Lung Cancer (NSCLC) Market

10.1. India Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Small Cell Lung Cancer (NSCLC) Market

11.1. Japan Non-Small Cell Lung Cancer (NSCLC) Market Overview

11.2. Japan Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Small Cell Lung Cancer (NSCLC) Market

12.1. Australia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market

13.1. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Small Cell Lung Cancer (NSCLC) Market

14.1. South Korea Non-Small Cell Lung Cancer (NSCLC) Market Overview

14.2. South Korea Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market

15.1. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market Overview

15.2. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Small Cell Lung Cancer (NSCLC) Market

16.1. UK Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Small Cell Lung Cancer (NSCLC) Market

17.1. Germany Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Small Cell Lung Cancer (NSCLC) Market

18.5. France Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Small Cell Lung Cancer (NSCLC) Market

19.9. Italy Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Small Cell Lung Cancer (NSCLC) Market

20.13. Spain Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market

21.1. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market Overview

21.2. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Small Cell Lung Cancer (NSCLC) Market

22.1. Russia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Small Cell Lung Cancer (NSCLC) Market

23.1. North America Non-Small Cell Lung Cancer (NSCLC) Market Overview

23.2. North America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Small Cell Lung Cancer (NSCLC) Market

24.1. USA Non-Small Cell Lung Cancer (NSCLC) Market Overview

24.2. USA Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Small Cell Lung Cancer (NSCLC) Market

25.1. Canada Non-Small Cell Lung Cancer (NSCLC) Market Overview

25.2. Canada Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Small Cell Lung Cancer (NSCLC) Market

26.1. South America Non-Small Cell Lung Cancer (NSCLC) Market Overview

26.2. South America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Small Cell Lung Cancer (NSCLC) Market

27.1. Brazil Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Small Cell Lung Cancer (NSCLC) Market

28.1. Middle East Non-Small Cell Lung Cancer (NSCLC) Market Overview

28.2. Middle East Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Small Cell Lung Cancer (NSCLC) Market

29.1. Africa Non-Small Cell Lung Cancer (NSCLC) Market Overview

29.2. Africa Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Small Cell Lung Cancer (NSCLC) Market Competitive Landscape And Company Profiles

30.1. Non-Small Cell Lung Cancer (NSCLC) Market Competitive Landscape

30.2. Non-Small Cell Lung Cancer (NSCLC) Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. F. Hoffmann-La Roche AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Merck & Co. Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. AbbVie Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Novartis AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Non-Small Cell Lung Cancer (NSCLC) Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca plc

31.4. GlaxoSmithKline Plc

31.5. Takeda Pharmaceutical Company Limited

31.6. Eli Lilly and Company

31.7. Amgen Inc.

31.8. Viatris Inc

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Regeneron Pharmaceuticals Inc.

31.11. Astellas Pharma Inc.

31.12. UCB S.A.

31.13. Sun Pharmaceutical Industries Ltd.

31.14. Dr. Reddy's Laboratories Ltd.

31.15. Aurobindo Pharma Limited

32. Global Non-Small Cell Lung Cancer (NSCLC) Market Competitive Benchmarking

33. Global Non-Small Cell Lung Cancer (NSCLC) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-Small Cell Lung Cancer (NSCLC) Market

35. Non-Small Cell Lung Cancer (NSCLC) Market Future Outlook and Potential Analysis

35.1 Non-Small Cell Lung Cancer (NSCLC) Market In 2028 - Countries Offering Most New Opportunities

35.2 Non-Small Cell Lung Cancer (NSCLC) Market In 2028 - Segments Offering Most New Opportunities

35.3 Non-Small Cell Lung Cancer (NSCLC) Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: F. Hoffmann-La Roche AG Financial Performance

Table 76: Merck & Co. Inc. Financial Performance

Table 77: AbbVie Inc. Financial Performance

Table 78: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Non-Small Cell Lung Cancer (NSCLC) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Non-Small Cell Lung Cancer (NSCLC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: F. Hoffmann-La Roche AG Financial Performance

Figure 76: Merck & Co. Inc. Financial Performance

Figure 77: AbbVie Inc. Financial Performance

Figure 78: Novartis AG Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Small Cell Lung Cancer Therapeutics Global Market Report 2024 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administrations), By End-Users (Hospitals, Cancer Therapy Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Urinary Tract Cancer Global Market Report 2024 – By Cancer Type (Bladder Cancer, Urethral Cancer, Ureteric And Renal Pelvic Cancer), By Treatment (Chemotherapy, Intravesical Therapy, Radiation Therapy, Surgery), By Diagnostic Techniques (Cystoscopy, Transurethral Resection Of The Tumor, Imaging Tests, Urine Analyses, Other Diagnostic Techniques), By Distribution Channel (Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blockchain Services Global Market Report 2024 – By Component (Tools, Services), By Application (Payments, Smart Contracts, Supply Chain Management, Governance, Risk, and Compliance Management, Identity Management, Other Applications), By End-use (BFSI, IT & Telecom, Healthcare, Retail, Manufacturing, Logistics, Government, Media & Entertainment, Energy and Utilities, Other End-Uses) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Boiler, Tank, And Shipping Container Global Market Report 2024 – By Type (Power Boiler and Heat Exchanger, Metal Tank (Heavy Gauge), Metal Can, Box, and Other Metal Container (Light Gauge)), By Product Type (Refrigerated Container, Dry Storage Container, Special Purpose Container, Flat Rack Container, Other Product Types), By Container Size (Small Containers, Large Containers, High Cube Container), By Application (Residential, Commercial, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Breast Cancer Drugs Global Market Report 2024 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bridges, Gateways And Routers Global Market Report 2024 – By Connectivity (Bluetooth, Wi-Fi, ZigBee, Ethernet, Cellular, Other Connectivity Types), By Application (Household, Commercial, Industry, Transportation), By End Use (Indoor, Outdoor) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Diagnostics Global Market Report 2024 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cervical Cancer Diagnostics Global Market Report 2024 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By Age Group (Below 21, Age between 21 to 29, Age between 30 to 65, Above 65), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the non small cell lung cancer NSCLC market?

How will the non small cell lung cancer NSCLC market drivers and restraints affect the non small cell lung cancer NSCLC market dynamics? What forces will shape the non small cell lung cancer NSCLC industry going forward?

The non small cell lung cancer NSCLC market major growth driver - rising tobacco consumption fuels growth in the non-small cell lung cancer (nsclc) market. For further insights on the non small cell lung cancer NSCLC market, request a sample here

What is the forecast market size or the forecast market value of the non small cell lung cancer NSCLC market?

The non-small cell lung cancer (nsclc) market size has grown rapidly in recent years. It will grow from $18.02 billion in 2023 to $20.1 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to evolution of immunotherapy, genomic profiling and precision medicine, expansion of clinical trials, smoking cessation initiatives. The non-small cell lung cancer (nsclc) market size is expected to see rapid growth in the next few years. It will grow to $29.95 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to emerging combination therapies, integration of artificial intelligence (ai), expansion of personalized vaccines, global collaborations in research, patient-centric care. Major trends in the forecast period include integration of telemedicine in oncology, liquid biopsy technologies, advances in diagnostic technologies, adoption of minimally invasive surgical techniques, immune checkpoint inhibitors. For further insights on the non small cell lung cancer NSCLC market, request a sample here

How is the non small cell lung cancer NSCLC market segmented?

The non small cell lung cancer NSCLC market is segmented
1) By Type: Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types
2) By Therapy: Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Other Distribution ChannelsFor further insights on the non small cell lung cancer NSCLC market, request a sample here

Which region has the largest share of the non small cell lung cancer NSCLC market? What are the other regions covered in the report?

North America was the largest region in the non-small cell lung cancer (NSCLC) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-small cell lung cancer (nsclc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the non small cell lung cancer NSCLC market, request a sample here.

Who are the major players in the non small cell lung cancer NSCLC market?

What are the key trends in the non small cell lung cancer NSCLC market?

Major trend in the non small cell lung cancer NSCLC market - Rising Focus Of Companies To Embrace Advance Treatments To Gain Competitive Advantage. For further insights on the non small cell lung cancer NSCLC market, request a sample here.

What are the major opportunities in the non small cell lung cancer NSCLC market? What are the strategies for the non small cell lung cancer NSCLC market?

For detailed insights on the major opportunities and strategies in the non small cell lung cancer NSCLC market, request a sample here.

How does the non small cell lung cancer NSCLC market relate to the overall economy and other similar markets?

For detailed insights on non small cell lung cancer NSCLC market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the non small cell lung cancer NSCLC industry?

For detailed insights on the mergers and acquisitions in the non small cell lung cancer NSCLC industry, request a sample here.

What are the key dynamics influencing the non small cell lung cancer NSCLC market growth? SWOT analysis of the non small cell lung cancer NSCLC market.

For detailed insights on the key dynamics influencing the non small cell lung cancer NSCLC market growth and SWOT analysis of the non small cell lung cancer NSCLC industry, request a sample here.